The EpiPen® hold time is now 3 seconds and there are other administration guidelines that the FDA has changed due to lacerations and injuries related to usage. There are three points of change listed below; however, you can read the FDAs document in its entirety:
Restrict Patient’s Leg, limit movement during epinephrine administration
Lacerations, bent needles and embedded needles have been reported when epinephrine has been injected into the thigh of a young child that is moving, kicking or uncooperative during administration. To minimize the risk of an injection-related injury it is advised that caregivers hold the child’s leg firmly in place and limit movement prior to and during the injection.
EpiPen® hold time is now 3 seconds
The EpiPen auto-injector should be held firmly in place for 3 seconds prior to removal.
Serious Infections at the Injection Site
Rare cases of serious skin and soft tissue infections, including necrotizing fasciitis and myonecrosis caused by Clostridia (gas gangrene), have been reported at the injection site following epinephrine injection for anaphylaxis. Advise patients to seek medical care if they develop signs or symptoms of infection, such as persistent redness, warmth, swelling, or tenderness, at the epinephrine injection site
This information came on the heals of the Minnesota Children’s Health Network finishing a revamp of their Anaphylaxis Action Plan, it was an honor to serve on the committee that examined and enhanced this Plan. The FDAs new administration guidelines will be included in the revamped Anaphylaxis Action Plan that is set to release just in time for the 2016-2017 school year.
If you’re looking for more information, be sure to: check out Mylan’s EpiPen® website, read the box insert of a newly filled EpiPen® prescription, contact a Mylan Customer Relations Representative at 800.395.3376 or speak with your physician.
PLEASE SHARE THIS IMPORTANT LIFE SAVING INFORMATION WITH OTHERS!!!